Markets › United States › NAS › AYTU

Aytu BioPharma Inc

NAS:AYTUHealthcarenasdaq_composite

$1.96−3.92%At closeAt close · Tue 20 Oct · ≈ AED 7.20 · Market cap $21.3M · Next earnings Mon 16 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	44.5%	52.0%	62.0%	75.3%	69.0%	64.0%	—	—
Operating margin	−89.7%	−113.7%	−15.9%	−2.4%	−11.8%	−14.4%	−11.8%	+2.7 pts
Net margin	−88.8%	−112.5%	−15.9%	−24.3%	−20.4%	−24.8%	−20.4%	+4.3 pts
EBITDA margin	−44.2%	−28.9%	−3.0%	2.2%	−7.0%	−7.6%	—	—
Return on equity	−42.4%	−245.5%	−43.3%	−57.2%	−71.5%	−40.4%	−71.5%	−31.1 pts
Return on assets	−21.9%	−79.0%	−12.4%	−13.3%	−10.9%	−13.6%	−10.9%	+2.7 pts
Return on capital employed	−37.7%	−150.2%	−24.8%	−2.8%	−12.8%	−16.5%	—	—
Debt / equity	0.2×	0.4×	0.8×	0.6×	1.2×	0.3×	1.2×	+289.3%
Debt / assets	11.7%	13.2%	22.1%	13.8%	18.5%	10.4%	—	—
Interest coverage	0.0×	−0.7×	−3.4×	−0.3×	−2.1×	−4.4×	—	—
Current ratio	1.0×	0.9×	1.1×	1.0×	1.3×	1.1×	1.3×	+11.1%
Quick ratio	0.8×	0.8×	0.9×	0.8×	1.1×	1.0×	—	—
Cash ratio	0.5×	0.3×	0.3×	0.3×	0.5×	0.5×	0.5×	+2.0%
Asset turnover	0.2×	0.7×	0.8×	0.5×	0.5×	0.5×	—	—
Inventory turnover	2.2×	4.3×	3.4×	1.3×	1.8×	3.0×	—	—
Receivables turnover	2.3×	4.5×	3.7×	2.8×	2.1×	2.5×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—